Patents by Inventor Wayne Cutfield

Wayne Cutfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING MYO-INOSITOL AND THEIR USE IN THE PREVENTION OF POST PARTUM HAEMORRHAGE (PPH)
    Publication number: 20230233588
    Abstract: The present invention relates generally to the field of compositions comprising myo- inositol for use in the prevention of post partum haemorrhage (PPH) and disorders and/or conditions linked thereto. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant, to a pregnant woman or to a woman who gave birth.
    Type: Application
    Filed: June 22, 2021
    Publication date: July 27, 2023
    Inventors: IRMA SILVA ZOLEZZI, KEITH MALCOLM GODFREY, SHIAO-YNG CHAN, WAYNE CUTFIELD
  • SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZER
    Publication number: 20220370378
    Abstract: The present invention relates generally to the field of insulin sensitizers. In particular, the present invention relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of hyperglycemia. The present invention further relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of disorders, conditions, and/or symptoms associated with hyperglycemia in a subject.
    Type: Application
    Filed: September 24, 2020
    Publication date: November 24, 2022
    Inventors: JOSE MANUEL RAMOS NIEVES, JEAN-PHILIPPE GODIN, IRMA SILVA ZOLEZZI, CHIARA NEMBRINI, KEITH MALCOLM GODFREY, SHIAO-YNG CHAN, WAYNE CUTFIELD
  • MYO-INOSITOL AND THE PREVENTION OF PRETERM BIRTH
    Publication number: 20220287988
    Abstract: The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of preterm birth and/or of conditions linked to preterm delivery in a female subject and/or in the offspring. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.
    Type: Application
    Filed: August 21, 2020
    Publication date: September 15, 2022
    Inventors: CHIARA NEMBRINI, IRMA SILVA ZOLEZZI, KEITH MALCOLM GODFREY, WAYNE CUTFIELD, SHIAO-YNG CHAN
  • MYO-INOSITOL AND THE PREVENTION OF PPROM
    Publication number: 20220287987
    Abstract: The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of a preterm-onset pre-labour rupture of membranes (PPROM) and disorders and/or conditions linked thereto. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.
    Type: Application
    Filed: August 21, 2020
    Publication date: September 15, 2022
    Inventors: SHIAO-YNG CHAN, KEITH MALCOLM GODFREY, WAYNE CUTFIELD, IRMA SILVA ZOLEZZI
  • METHODS AND USES OF AN EXTRACT FROM OLIVE LEAF IN MANAGEMENT OF TYPE 2 DIABETES
    Publication number: 20150224161
    Abstract: Described herein are methods and uses of oleuropein and hydroxytyrosol in a variety of applications to prevent, reduce symptoms of and treat conditions related to insulin sensitivity including type 2 diabetes.
    Type: Application
    Filed: September 4, 2013
    Publication date: August 13, 2015
    Inventors: Martin De Bock, Stephen Hodgkinson, Wayne Cutfield, Ralf Christian Schlothauer
  • Enhanced method of treatment of growth disorders
    Publication number: 20070037861
    Abstract: The application relates to the treatment of conditions and diseases for which growth hormone is a desirable method of treatment, using free fatty acid regulators in combination with growth hormone. In particular, the present invention discloses an enhanced method of treatment of growth disorders as well as methods to prevent and/or reduce adverse consequences of growth hormone treatment.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 15, 2007
    Applicant: PFIZER HEALTH AB
    Inventors: Wayne Cutfield, Paul Hofman, Mark Vickers
  • Therapy for growth hormone induced insulin resistance in juveniles with growth disorders
    Publication number: 20050043231
    Abstract: This invention provides compositions and methods for treating adverse effects of growth hormone therapy in animals that are small for gestational age or suffered from intrauterine growth restriction. Methods include providing growth hormone to increase growth rates, and includes co-administration of an insulin sensitiser, such as a biguanide or a thiazolidinedione. In other embodiments, combinations of insulin sensitisers can be co-administered along with growth hormone.
    Type: Application
    Filed: December 23, 2002
    Publication date: February 24, 2005
    Inventors: Wayne Cutfield, Paul Hofman, Bernhard Breier